Vaccines Redefined
Program | Pre-clinical | GMP | Phase I or I/II | Phase II |
---|---|---|---|---|
Biodefence |
||||
Botulinum Toxin |
✔ |
✔ |
○ |
○ |
VEE/EEE/WEE |
✔ |
✔ |
○ |
○ |
Filovirus |
✔ |
✔ |
○ |
○ |
Smallpox | ✔ |
○ |
○ |
○ |
Program | Pre-clinical | GMP | Phase I or I/II | Phase II |
---|---|---|---|---|
Infectious Disease |
||||
CMV |
✔ |
✔ |
✔ |
○ |
HIV - monovalent |
✔ |
✔ |
✔ |
○ |
HIV - multivalent |
✔ |
✔ |
○ |
○ |
Influenza - young adults, elderly |
✔ |
✔ |
✔ |
○ |
Pandemic Influenza - H1B & H5 |
✔ |
✔ |
✔ |
○ |
RSV |
✔ |
✔ |
○ |
○ |
HSV-2 |
✔ |
✔ |
○ |
○ |
SARS |
✔ |
✔ |
○ |
○ |
Program | Pre-clinical | GMP | Phase I or I/II | Phase II |
---|---|---|---|---|
Cancer Immunotherapy |
||||
CEA(gastrointestinal cancers) |
✔ |
✔ |
✔ |
○ |
Her2 (breast cancer) |
✔ |
✔ |
✔ |
* |
TRP2 (melanoma) |
✔ |
○ |
○ |
○ |
VRP adjuvant technology |
✔ |
○ |
○ |
○ |
PSMA (prostate cancer) |
✔ |
✔ |
✔ |
○ |
✔ Completed | ○ In planning/Underway |*Underway